CytoDyn (CYDY) Operating Income (2010 - 2026)
CytoDyn (CYDY) posted Operating Income of -$6.3 million for Q1 2026, up 70.94% on a QoQ basis from -$21.7 million in Q4 2025, and down 57.46% year-over-year from -$14.8 million in Q1 2025.
CytoDyn (CYDY) Operating Income (2010 - 2026) Analysis & Trends
CytoDyn's Operating Income history runs 17 years deep, the most recent figure standing at -$6.3 million for Q1 2026.
- Quarterly Operating Income fell 57.46% year-over-year to -$6.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$38.0 million (down 569.57% YoY) and the FY2025 annual result came in at $9.7 million, up 153.5% from the prior year.
- Operating Income was -$6.3 million for Q1 2026 at CytoDyn, up from -$21.7 million in the prior quarter.
- Across five years, Operating Income topped out at $22.4 million in Q3 2024 and bottomed at -$79.0 million in Q2 2022.
- A 5-year average of -$10.6 million and a median of -$4.9 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income surged 586.49% — and 2025, when it slumped 485.06%.
- CytoDyn's Operating Income stood at -$23.2 million in 2022, then soared by 85.33% to -$3.4 million in 2023, then dropped by 9.09% to -$3.7 million in 2024, then slumped by 485.06% to -$21.7 million in 2025, then jumped by 70.94% to -$6.3 million in 2026.
- Business Quant data shows CYDY's Operating Income at -$6.3 million in Q1 2026, -$21.7 million in Q4 2025, and -$4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | -6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -6.30 Mn |
| Nov 30, 2025 | -21.69 Mn |
| Aug 31, 2025 | -4.95 Mn |
| May 31, 2025 | -5.07 Mn |
| Feb 28, 2025 | -4.00 Mn |
| Nov 30, 2024 | -3.71 Mn |
| Aug 31, 2024 | 22.44 Mn |
| May 31, 2024 | -6.63 Mn |
| Feb 29, 2024 | -3.41 Mn |
| Nov 30, 2023 | -3.40 Mn |
| Aug 31, 2023 | -4.61 Mn |
| May 31, 2023 | -3.78 Mn |
| Feb 28, 2023 | -3.92 Mn |
| Nov 30, 2022 | -23.16 Mn |
| Aug 31, 2022 | -9.71 Mn |
| May 31, 2022 | -79.05 Mn |
| Feb 28, 2022 | -19.40 Mn |
| Nov 30, 2021 | -25.32 Mn |
| Aug 31, 2021 | -21.64 Mn |
| May 31, 2021 | -23.64 Mn |